Howard B. Schiller
2014
In 2014, Howard B. Schiller earned a total compensation of $27.1M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International, a 584% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,400,000 |
|---|---|
| Salary | $953,846 |
| Stock Awards | $23,730,659 |
| Other | $23,067 |
| Total | $27,107,572 |
Schiller received $23.7M in stock awards, accounting for 88% of the total pay in 2014.
Schiller also received $2.4M in non-equity incentive plan, $953.8K in salary and $23.1K in other compensation.
Rankings
In 2014, Howard B. Schiller's compensation ranked 65th out of 13,032 executives tracked by ExecPay. In other words, Schiller earned more than 99.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 65 out of 13,032 | 100th |
Division Manufacturing | 22 out of 4,967 | 100th |
Major group Chemicals And Allied Products | 8 out of 1,690 | 100th |
Industry group Drugs | 8 out of 1,369 | 99th |
Industry Pharmaceutical Preparations | 8 out of 1,042 | 99th |
Source: SEC filing on April 29, 2016.
Schiller's colleagues
We found six more compensation records of executives who worked with Howard B. Schiller at Valeant Pharmaceuticals International in 2014.
2014
Ari Kellen
Valeant Pharmaceuticals International
Group Chairman
2014
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2014
Pavel Mirovsky
Valeant Pharmaceuticals International
President and General Manager, Europe
2014
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2014
Debora Jorn
Valeant Pharmaceuticals International
Group Chairman
2014
Brian Stolz
Valeant Pharmaceuticals International